1. Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act

   Zijp, T. R., Toren-Wielema, M. L., Nannan Panday, P. V., Kosterink, J. G. W., Berger, S. P. & Touw, D. J., 2020, In : Therapeutic Drug Monitoring.

   Research output: Contribution to journal › Letter › Academic › peer-review

2. Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study

   Dutch Pharmacology Oncology Grp, Oct-2019, In : Therapeutic Drug Monitoring. 41, 5, p. 561-567 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Does Circadian Rhythm affect the Pharmacokinetics of Once-Daily Tobramycin in Adults with Cystic Fibrosis?

   van Maarseveen, E. M., van der Meer, R., Neef, C., Heijerman, H. G. M. & Touw, D. J., 11-Feb-2020, In : Therapeutic Drug Monitoring. 18 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Official International Association for Therapeutic Drug Monitoring and Toxicology guideline: Development and Validation of Dried Blood Spot-based Methods for Therapeutic Drug Monitoring

   Capiau, S., Veenhof, H., Koster, R., Bergqvist, Y., Boettcher, M., Halmingh, O., Keevil, B., Koch, B., Linden, R., Pistos, C., Stolk, L., Touw, D., Stove, C. & Alffenaar, J-W., Aug-2019, In : Therapeutic Drug Monitoring. 41, 4, p. 409-430 22 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for Osteosarcoma: Reversible impaired methotrexate clearance after platinum-based chemotherapy for osteosarcoma

   Oude Munnink, T. H., van der Meer, A., de Haan, J. J., Touw, D. J. & van Kruchten, M., Dec-2019, In : Therapeutic Drug Monitoring. 41, 6, p. 693-695 3 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (75) »